These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 7273761

  • 21. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [Abstract] [Full Text] [Related]

  • 22. Hormonal pattern of adolescent menstrual cycles.
    Apter D, Viinikka L, Vihko R.
    J Clin Endocrinol Metab; 1978 Nov; 47(5):944-54. PubMed ID: 122422
    [Abstract] [Full Text] [Related]

  • 23. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT, Hershman JM, Boyd AE, Longcope C, Bacharach P.
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [Abstract] [Full Text] [Related]

  • 24. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Swahn ML, Bygdeman M, Cekan S, Xing S, Masironi B, Johannisson E.
    Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
    [Abstract] [Full Text] [Related]

  • 25. The effect of levonorgestrel administered in large doses at different stages of the cycle on ovarian function and endometrial morphology.
    Landgren BM, Johannisson E, Aedo AR, Kumar A, Shi YE.
    Contraception; 1989 Mar; 39(3):275-89. PubMed ID: 2496951
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
    Heikinheimo O, Gordon K, Williams RF, Hodgen GD.
    Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
    [Abstract] [Full Text] [Related]

  • 27. The menstrual cycle in women using an intrauterine device.
    Faundes A, Segal SJ, Adejuwon CA, Brache V, Leon P, Alvarez-Sanchez F.
    Fertil Steril; 1980 Nov; 34(5):427-30. PubMed ID: 7439408
    [Abstract] [Full Text] [Related]

  • 28. Hormonal profile in IUD users.
    Souka AR, Rahman H, Osman M, Mohei Y, Rizk M.
    Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
    [Abstract] [Full Text] [Related]

  • 29. Levels of serum steroid hormones in intrauterine contraceptive device users.
    Fahmy K, el-Gazar A, Eisa I, Ghonaim M, Saad S, Afifi A.
    Gynecol Endocrinol; 1991 Mar; 5(1):1-5. PubMed ID: 1897380
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state.
    de Kretser DM, Burger HG, Dumpys R.
    J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423
    [Abstract] [Full Text] [Related]

  • 35. Pituitary-ovarian function after tubal ligation.
    Alvarez-Sanchez F, Segal SJ, Brache V, Adejuwon CA, Leon P, Faundes A.
    Fertil Steril; 1981 Nov; 36(5):606-9. PubMed ID: 7308505
    [Abstract] [Full Text] [Related]

  • 36. Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.
    Sheehan KL, Casper RF, Yen SS.
    Am J Obstet Gynecol; 1979 Nov 15; 135(6):759-63. PubMed ID: 386801
    [Abstract] [Full Text] [Related]

  • 37. Decreased follicular phase gonadotropin secretion is associated with impaired estradiol and progesterone secretion during the follicular and luteal phases in normally menstruating women.
    Schweiger U, Laessle RG, Tuschl RJ, Broocks A, Krusche T, Pirke KM.
    J Clin Endocrinol Metab; 1989 May 15; 68(5):888-92. PubMed ID: 2497129
    [Abstract] [Full Text] [Related]

  • 38. Studies on the pattern of circulating steroids in the normal menstrual cycle. I. Simultaneous assays of progesterone, pregnenolone, dehydroepiandrosterone, testosterone, dihydrotestosterone, androstenedione, oestradiol and oestrone.
    Guerrero R, Aso T, Brenner PF, Cekan Z, Landgren BM, Hagenfeldt K, Diczfalusy E.
    Acta Endocrinol (Copenh); 1976 Jan 15; 81(1):133-49. PubMed ID: 128969
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F, Louvet JP, Moatti JP, Smilovici W, Duguet L, Boulard C.
    J Gynecol Obstet Biol Reprod (Paris); 1975 Jan 15; 4(7):915-26. PubMed ID: 767402
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.